Introduction
Vein of Galen aneurysmal malformation (VGAM) is a rare congenital intracranial arteriovenous deformation resulting from an anomalous fistulous connection between the primitive choroidal vessels and the most proximal part of the median prosencephalic vein of Markowski (MProsV). The incidence has been reported as 1:25,000. 1 It accounts for 1% of cerebral vascular malformations and 30% of pediatric vascular malformations. 2 Clinically, VGAM is commonly diagnosed during the neonatal period and early childhood according to the symptoms of congestive heart failure and intracranial hypertension.
Steinheil first described this abnormal intracranial arteriovenous connection as "varix aneurysm" in 1895. 3 Since then, there were various terms used to depict this condition, including "vein of Galen malformation," "vein of Galen aneurysmal formation," "arteriovenous aneurysms of the vein of Galen," and "aneurysms of the vein of Galen." However, these medical terms are misnomers because the malformation is actually caused by MProsV, rather than the vein of Galen. The true VGAM was reported by Boldrey and Miller in 1949. 4 The term of vein of Galen "aneurysms" was first proposed by Jaeger et al in 1937. 5 In current understanding, the word, "aneurysms," is also an description error. This tendency is arbitrary since the word is derived from the Greek aneurynein, that is, to dilate. Therefore, the use of a "venous aneurysms" is etymologically legitimate rather than a misnomer. 6 Endovascular embolization is generally considered to be the first-line therapeutic option. A meta-analysis performed by Yan et al 7 revealed that the mortality rate of embolized patients decreased from 17 to 12% from 1980s to 2000s. But the management is still challenging. This article reviewed the pathogenesis, classification, clinical manifestations, imaging of VGAM, and summarized the key points of endovascular embolization to improve the rate of treatment and prognosis for VGAM. of the MProsV persists as the vein of Galen, while the anterior portion regresses in parallel with the formation of the internal cerebral veins. The remnants of the MProsV then join the internal cerebral veins to form the vein of Galen, which may cause the existence of connection between the VGAM and the deep venous system. Raybaud and Strother 8 identified the dilated venous structure as the MProsV at first. The arteriovenous connection between primitive choroidal vessels and MProsV leads to hemodynamic abnormalities, which results in the obstruction of embryologic vein regression and the development of vein of Galen. Subsequently, the high-output arteriovenous connection contributes to venous hypertension and aneurysmal dilation of MProsV. Besides, stenosis of dural sinuses is another cause of the dilatation, resulting from the rapid and turbulent flow caused by the arteriovenous connection.
The drainage of the malformation is toward the straight sinus, and it also drains into sagittal sinus through the persistent falcine sinus, in this case the straight sinus is absent, hypogenetic or stenotic. 9 The cases of VGAM with persistent falcine sinus have been reported previously by us 10 (►Fig. 2). The arteriovenous deformation is supplied by a variety of arterial feeding vessels including subependymal network originating from the posterior circle of Willis, thalamoperforating arteries, choroidal arteries, and the limbic arterial arch. 4 It is located in the cistern of velum interpositum as well as the quadrigeminal cistern, and there is no connection between the malformation and the deep venous system, which has been considered traditionally. However, this theory has been challenged in recent literature reports. [11] [12] [13] In these studies, the drainage of the malformation into the deep venous system has been confirmed by follow-up imaging, including internal cerebral veins, straight sinus, falcine sinus, basal vein of Rosenthal, and inferior sagittal sinus.
The genetic susceptibility to VGAM is still unclear, while there are some potentially causative genes reported in Fig. 1 The formation of VGAM. 25 (A) Normal vessel structure between the pericallosal arteries and the PCA is present in embryonic period. (B) The abnormal high-output arteriovenous connection contributes to aneurysmal dilation of the MProsV, which leads to the formation of VGAM. This connection drains into the SS and subsequently into T. In addition, it also bloods into the FS and then into the AT when the SS is absent, hypogenetic, or stenotic. Reproduced with permission from Mortazavi et al. 25 AT, accessory torcula; FS, falcine sinus; MProsV, median prosencephalic vein; MRI, magnetic resonance imaging; PCA, posterior cerebral arteries; SS, straight sinus; T, trocula; VGAM, vein of Galen aneurysmal malformation.
Fig. 2
Cranial sagittal MRI in a patient with VGAM reveals a dilated MProsV (short arrow) connected with a persistent falcine sinus (long arrow) blooded into the sagittal sinus and the absence of straight sinus on T1WI (A) and T2WI (B). MProsV, median prosencephalic vein; MRI, magnetic resonance imaging; VGAM, vein of Galen aneurysmal malformation; WI, weighted imaging. RASA1 gene mutation in two patients with VGAM. Chida et al 15 reported one variant of ACVRL1 in a case with VGAM. Tsutsumi et al 16 published a patient with VGAM carrying a mutation in the ENG gene encoding endoglin; this patient presented with a family history of hereditary hemorrhagic telangiectasia and the authors hypothesized the gene might be etiologically related to VGAM. Additionally, Xu et al 17 reported a familial VGAM in an adult female patient with VGAM, who had a history of a stillbirth pregnancy caused by VGAM. However, the relationship between genetic factors and VGAM needs to be further investigated.
Classification

Vein of Galen Aneurysmal Malformation
The first classification of VGAM was proposed by Litvak et al 18 in 1960. There are two most widely accepted classifications described by Lasjaunias and Yasargil, respectively (►Table 1). Based on the age at presentation and angioarchitecture of the fistulae, Lasjaunias et al 19 divided VGAM into two types: choroidal type and mural type (►Fig. 3). 20 The choroidal type is the most common type accounting for 56 to 76% of all VGAMs and is common in males. 21 It mainly occurs in neonates, 22 characterized by congestive heart failure due to a high flow fistula. In choroidal type, multiple arterial feeders like a nidus shunt into the anterior aspect of MProsV. The feeder vessels mostly come from the choroidal arteries, involving the anterior and posterior choroidal, anterior cerebral, as well as quadrigeminal and thalamoperforating arteries occasionally. 23 In mural type, one or more arteriovenous fistulae (AVF) shunt into the inferolateral margin in the wall of MProsV with lower flow. The arterial feeders arise from unilateral or bilateral quadrigeminal arteries and posterior choroidal arteries. Clinically, it is common in infants and children associated with the symptoms of macrocephaly, hydrocephalus, and developmental delay. Due to slow flow and few fistulae, it has a better prognosis, and thrombosis is more common in this type compared with choroidal type.
Yasargil 24 dichotomized VGAM into four types according to whether the malformation is a pure AVF (types I-III) or an arteriovenous malformation (AVM) with or without associated AVF (types IVA-C), and the exact origin of the feeding arteries. Type I is a pure AVF between posterior cerebral artery (P4 and its branches), anterior or posterior pericallosal arteries, and the vein of Galen. Type II is the fistulous connection between the thalamoperforators (basilar and P1 segment) and the vein of Galen. Type III is a mixture of type I and II, which is the commonest type. Type IV comprises three subtypes. Type IVA is similar to type IVB. Both types IVA and IVB are aneurysmal dilation of the vein of Galen caused by shunting from an adjacent thalamic and mesencephalic AVM, respectively. Type IVC is a thalamomesencephalic or mesodiencephalic plexiform malformation along with an adjacent and separate cisternal AVF to the vein of Galen. 25, 26 Though the Yasargil's classification is classic and widely recognized, there are several deficiencies. The clinical presentation and outcome are not involved in the Yasargil's classification. 
Vein of Galen Aneurysmal Dilatation
Vein of Galen aneurysmal dilatation (VGAD) refers to the dilated vein of Galen arising from the drainage of an AVM into the true vein of Galen rather than the precursor of the vein of Galen. It belongs to the group of dura AVM. Different from VGAM, it is a real malformation of Galen vein and contacted with the deep venous system. The arterial supply comprises the internal carotid artery, meningeal branches of internal and external carotid artery, normal sinus, the drainage from Galen vein into brain parenchyma, and mesencephalic or diencephalic AVM. 27 Based on the source of abnormal blood, VGAD can be differentiated into (1) 
Vein of Galen Varices
Vein of Galen varices is the varicose dilatation of the Galen vein without an arteriovenous shunt. There are two types of the vein of Galen varices in children. The first type is a transient dilatation of the Galen vein accompanied with heart failure caused by other origins. This type is asymptomatic and cardiac function is improved along with the disappearance of the dilatation. The second type occurs when flowing a complete hemisphere into the deep venous system. It is also asymptomatic, but the venous ischemia disorders may occur as a result of insufficient venous drainage. 25 
Clinical Manifestations
Clinical presentations vary with the age of onset and vascular architecture. Additionally, Lasjaunias et al 22 recommended the Bicêtre neonatal evaluation score system, which takes into account neurological, cardiac, respiratory, renal, and hepatic functions (►Table 2). It helps to estimate the comprehensive symptoms of patients with VGAM and assists with the therapeutic decision. A score of less than 8 indicates a poor outcome needing expectant treatment. An emergency endovascular treatment is advised relating to a score of 8 to 12. The embolization can be delayed until 5 months of age associated with a score of 13 to 21. Besides, the evaluation of the neurocognitive status could be performed using the Denver test and the Brunet-Lézine test. 34 Imaging VGAM is one of the diseases mostly diagnosed prenatally with the proportion of approximately 40%. 35 However, a retrospective analysis of 25 patients with VGAM conducted by Geibprasert et al 36 showed there was no relevance between early prenatal diagnosis and the follow-up outcome. But it assisted in the decision of therapy plan and facilities. Prenatal diagnosis is usually made during the third trimester of pregnancy by ultrasonography according to the visualization of an anechogenic or hypoechogenic round or ovoid structure with regular borders located in the midline of the posterior part of the third ventricle. Enough dilatation of the malformation is required if it can be detected on the first-or even second-trimester ultrasound 36 and the conformation of the antenatal diagnosis is usually performed by color Doppler imaging and magnetic resonance imaging (MRI). There is an antenatal VGAM classification including isolated VGAM, when VGAM is the only manifestation and associated VGAM, when VGAM is associated with cardiac and neurological abnormalities. 37 However, it might be challenged in the future research. Termination of pregnancy should be performed when fetal hydrops and serious heart failure occur.
The chest radiograph shows cardiomegaly resulting from congestive heart failure. Brain radiograph may display a rim of calcification within the wall of the aneurysmal sac, which is considered to be a poor indicator associated with the tendency of subsequent thrombosis. 25 Cranial computed tomography (CT) usually displays a spherical mass located in the quadrigeminal cistern or the cistern of velum interpositum. Dilated ventricular system, periventricular white matter hypodensities, and diffuse cerebral atrophy are usually associated MRI findings (►Fig. 4). MRI has the advantage to accurately demonstrate the location of the lesion, vascular architecture, and status of vessel drainage in the VGAM malformation (►Fig. 5); furthermore, the position and identity of major arterial trunks, primary branches as well as secondary branches feeding the fistula are better recognized on brain MRI than on cranial CT. 38 Additionally, parenchymal changes including focal encephalomalacia and diffuse brain volume loss can also be visible in CT and MRI, which are considered to be predictors of poor outcome. 36 Angiography (including MR angiography and CT angiography) remains the gold standard for the diagnosis. It has advantages in revealing the site, size, morphology, and abnormal flow dynamics of vessels (►Fig. 6). Similarly, it better shows the small feeders supplying the fistula, as well as the dynamic aspects of the venous drainage into the normal brain and hemodynamics of the arteriovenous shunt. 26, 35 Strategies for the decision of treatment can be made according to the evidence on angiography. In future applications, four-dimensional flow MRI is probably useful in the management and monitoring intracranial hemodynamic alteration during embolizations, to estimate the efficacy and risk of reperfusion complications. 39 Wu et al 40 indicated that it assisted in detecting the arteriovenous shunt flow, cerebral vessel inflow, and cerebral flow redistribution after embolizations during staged embolizations of six patients with VGAM.
The spontaneous thrombosis of VGAM is rare and the underlying causal mechanism is not entirely understood. There are multifactors described including the alteration of hemodynamics (slow flow, increased pressure, or turbulence), vascular spasm, vascular proliferation, and regressive atherosclerotic changes in the vessels. 41, 42 The ventricular shunting and the use of contrast media for angiography are also considered to be correlated with the thrombosis of VGAM. 41 The imaging investigation can well demonstrate the features of thrombosis. On CT, it reveals heterogeneous signal associated with calcified capsule occasionally. Contrast-enhanced CT shows a central thrombus and peripheral circulating blood along the wall of the sac, called "targetsign." 26 MRI of the thrombosis VGAM displays extracellular methemoglobin in the central part and hemosiderin in the peripheral part of lesion. 43 
Management
The purpose of therapy is various according to the age of onset. In newborns, the goal of therapy is mainly the correction of heart failure, while in older children the aim is to improve the neurological symptoms. 4 It is advised that the therapy outcome is to reverse the pathophysiologic effects caused by the arteriovenous deformation rather than to obtain a complete normal morphologic appearance. 44 The management of VGAM includes a combination of surgical approaches, endovascular treatments, radiosurgery, and conservative treatments. Endovascular embolization is the preferred treatment and others are considered to be the complementary options, when embolization is limited. Fig. 4 Axial CT scan of brain in a patient with VGAM reveals a large homogeneous, well-defined spherical mass associated with dilated third and lateral ventricles and hydrocephalus because of the compression of the aqueduct, as well as periventricular white matter hypodensities (arrows). CT, computed tomography; VGAM, vein of Galen aneurysmal malformation.
Surgery and Radiosurgery
Though the method of surgery is widely used, the complete resection and surgical clipping of the vessels are still challenging with higher morbidity and mortality. The problem is associated with surgery including the deep location of the lesion, high-flow shunt, complex vascular architec-ture, and poor tolerance in infants. Therefore, surgery is usually considered as a complementary approach when embolization is failed. Additionally, ventricular shunting may exacerbate the cerebral venous hypertension and brain ischemia due to the alteration of venous drainage. Hence, ventricular shunting should be performed after embolization. 22, 26 Similarly, the approach of Gamma knife surgery is also a complementary alternative since it does not reduce the size of the lesion immediately. Stereotactic radiotherapy may have an effect on some patients with VGAM, but its effect is still not clear. Besides, there is controversy about the lesion to the development of brain.
Endovascular Therapy
The first case treated by embolization was reported in 1950 by Davis. 45 With the development of endovascular treatment, the mortality rate has dropped from 60-82% to 11%. 46 The goal of endovascular therapy is to reduce intracranial shunting or even occlude all the fistulae (►Fig. 7). In fact, total obliteration is not necessary because a reduction in one-third to half of the shunt is enough to correct the clinical symptoms. 47 Recently, a meta-analysis showed the predominant complications of endovascular treatment consisted of cerebral vessel perforation, hemorrhage, cerebral ischemia, hydrocephalus, and leg ischemia. 7 The prevention of complications depends on proper super selective embolization, selection of embolic material and exact technique, as well as preservation of normal cerebral deep venous drainage. Additionally, the existence of normal drainage between deep venous system and VGAM should be considered before embolization in case of the occurrence of adverse effects to the normal cerebral vessel after endovascular management.
Although it is difficult to be seen through angiograms or noninvasive imaging presumably due to technical factors and hemodynamics, the drainage is a critical element of the treatment planning. 11 There are two options of embolization including transarterial and transvenous approach, of which the transarterial route is preferred. Umbilical artery approach can be used for embolization in the early neonatal period, and the femoral artery is an alternative route when the umbilical artery is not available. As for transvenous approach, there is a controversy regarding the outcome of transvenous embolization. In previous literature, it was considered to be not feasible due to increased morbidity. In recent article, Orlov et al 48 considered it was a safe and effective salvage method for VGAM with restricted transarterial access. Besides, Meila et al 49 described a combined transvenous and transarterial approach, called kissing microcatheter technique. It was considered to be a safe method with lower complication rate and the overall outcome can be improved, particularly in the neonate with congestive heart failure. The embolic agents comprise coils, microballoons, N-butyl-cyanoacrylate (NBCA), Onyx liquid, and ethylene vinyl alcohol copolymer. In choroidal type of VGAM, Onyx is recommended because of the advantage of more definitive and stable occlusion. In mural type, NBCA is a preferred embolic material due to the properties of quick precipitation and adhesion to vessel. 48 In addition, Joo et al 42 first reported a patient with a mural-type VGAM who was successfully treated using the Micro Vascular Plug system, which may be a potential available option.
The staged embolization is recommended to minimize the occurrence of complications such as a normal perfusion pressure breakthrough phenomenon or a multiple venous thrombosis. 11 The interval is usually 3 to 6 months. 4, 23 There is a new classification scoring system for the decision of treatment proposed by Mortazavi et al, 25 which combines arterial feeders with clinical symptoms and age (►Table 3). Embolization is not urgent and one stage of embolization is suggested for patients with a score of 0 to 1. Urgent embolization and multiple stages of treatment are recommended when the score is 2 points. Embolization in multiple stages or palliative treatment is advised for patients with a score of 3.
The time of endovascular management depends on the clinical symptom and is preferably at the age of 5 to 6 months for maximum safety and efficacy of treatment. 26 However, symptoms related to the possible progression of the heart failure and the potential development of hydrocephalus need to be closely followed up 50 . The decision of management can be evaluated by the Bicêtre scoring system proposed by Vein of Galen Aneurysmal Malformation Cao, Cai 51 This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
Alvarez et al 4 (►Table 2). A score of more than 12 suggests the clinical symptom is stable and it is better to prolong therapy until the age of 5 to 6 months. Endovascular embolization is recommended when a score is between 8 and 12. There is no indication for embolization associated with a score of less than 8.
VGAD is the pathological dilatation of Galen vein due to the stenosis or obstruction of the outflow. The degree of dilatation is varied with the extent of stenosis. So, the treatment of VGAD with high flow is mainly planned embolization or stereotactic radiotherapy. For low level VGAD, intravascular embolization is the major approach of management. 27 It is associated with a good prognosis in comparison with VGAM because VGAM has high morbidity and mortality due to refractory high-output heart failure and neurological damage. 51 As for the vein of Galen varices, it has lower hemorrhage risk and better outcome. The adverse consequence may occur as a result of an inappropriate surgical or interventional management. Conservative treatment is recommended for patients with stable symptoms, 52 and close follow-up with imaging investigations is essential.
Prognosis
Without treatment, more than 90% of patients with VGAM die in the neonatal and infant period. A meta-analysis about the outcome and complications of endovascular embolization for VGAM revealed the proportion of the good outcome increased from 49 to 70% from 1980s to 2000s. 7 But the morbidity and mortality are still very high. There are some factors that correlated with the clinical outcome involving embolization technology, clinical presentation (multiorgan failure and neurological symptoms), and imaging findings (extensive encephalomalacia, arterial steal, parenchymal calcification, and high-flow multifeeder shunts). 36 Additionally, the choroidal type of VGAM has worse prognosis than mural type. Agarwal et al 53 retrospectively analyzed 36 patients with VGAM and concluded that jugular atresia was significantly associated with poor outcome. A systematic review conducted by Yan et al 54 showed the outcome was good in the patient with an early spontaneous thrombosis, while the outcome was poor in the late stages of the VGAM with spontaneous thrombosis.
The main sequela of VGAM is represented by permanent neurological deficit with intellectual disability and epilepsy. The evaluation of therapy outcome in patients with VGAM can be performed by the system of Bicêtre admission and outcome score proposed by Lasjaunias et al 22 (►Table 4). This scoring system can help to estimate the effect of clinical treatment, contribute to correct the therapy approaches, and improve the level of management of VGAM.
In this study, we performed a literature retrospective of relevant articles in the recent 15 years using the database of PubMed (https://www.ncbi.nlm.nih.gov/pubmed) with the key words "vein of Galen aneurysmal malformation" or "VGAM." The detail information was collected, including age, sex, types of VGAM, clinical feature, treatment, and outcome (►Tables 5 and 6). A total of 43 patients (36 children and 7 adults) were enrolled. We found that the mortality of VGAM was still high. The prognosis of VGAM in adult was better than children, and the mural type was associated with a good outcome compared with choroid type. 
Conclusion
VGAM is a rare congenital intracranial arteriovenous deformation associated with high mortality. To increase and ameliorate the VGAM diagnosis and therapy, it is crucial to fully understand the pathogenesis, clinical classification, and features of this condition. Imaging plays an important role in the visualization of vascular architecture and also in assisting the treatment with embolization procedures. The evaluation of the time and stages for endovascular treatment based on the score systems will be beneficial to decrease the complication rate, morbidity, and mortality. 
